BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38752748)

  • 21. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?
    Cui B; Lin L; Wang B; Liu W; Sun C
    Pharmacol Res; 2022 Jan; 175():106022. PubMed ID: 34883213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
    Gopalan S; Ganapathy S; Mitra M; Neha ; Kumar Joshi D; Veligandla KC; Rathod R; Kotak BP
    Cureus; 2023 Oct; 15(10):e46314. PubMed ID: 37927652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
    Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
    Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Growth Characterization of a Novel Strain of
    Hossain MN; Afrin S; Humayun S; Ahmed MM; Saha BK
    Front Nutr; 2020; 7():27. PubMed ID: 32309286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
    Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
    PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the impact of polypeptide-p on diabetic rats upon its cloning, expression, and secretion in Saccharomyces boulardii.
    Yamchi A; Rahimi M; Javan B; Abdollahi D; Salmanian M; Shahbazi M
    Arch Microbiol; 2023 Dec; 206(1):37. PubMed ID: 38142245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-promoting properties of
    Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
    Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
    [No Abstract]   [Full Text] [Related]  

  • 29. Quality control of fifteen probiotic products containing Saccharomyces boulardii.
    Vanhee LM; Goemé F; Nelis HJ; Coenye T
    J Appl Microbiol; 2010 Nov; 109(5):1745-52. PubMed ID: 20636342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota.
    Gu Y; Wang C; Qin X; Zhou B; Liu X; Liu T; Xie R; Liu J; Wang B; Cao H
    Pharmacol Res; 2022 Jul; 181():106291. PubMed ID: 35690329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotic properties of yeasts in traditional fermented foods and beverages.
    Tamang JP; Lama S
    J Appl Microbiol; 2022 May; 132(5):3533-3542. PubMed ID: 35094453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Saccharomyces fungemia: A systematic review.
    Vinayagamoorthy K; Pentapati KC; Prakash H
    Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Lenka S; Singh D; Paul S; Gayen A; Chandra M
    ACS Infect Dis; 2021 Apr; 7(4):733-745. PubMed ID: 33703881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Engineering of Probiotic Saccharomyces boulardii.
    Liu JJ; Kong II; Zhang GC; Jayakody LN; Kim H; Xia PF; Kwak S; Sung BH; Sohn JH; Walukiewicz HE; Rao CV; Jin YS
    Appl Environ Microbiol; 2016 Apr; 82(8):2280-2287. PubMed ID: 26850302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcoholic and non-alcoholic rosé wines made with Saccharomyces cerevisiae var. boulardii probiotic yeast.
    Mulero-Cerezo J; Tuñón-Molina A; Cano-Vicent A; Pérez-Colomer L; Martí M; Serrano-Aroca Á
    Arch Microbiol; 2023 Apr; 205(5):201. PubMed ID: 37081186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Tunable and Expandable Transactivation System in Probiotic Yeast
    Kwak S; Mahmud B; Dantas G
    ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trehalose Protects the Probiotic Yeast
    Moon JE; Heo W; Lee SH; Lee SH; Lee HG; Lee JH; Kim YJ
    J Microbiol Biotechnol; 2020 Jan; 30(1):54-61. PubMed ID: 31546305
    [No Abstract]   [Full Text] [Related]  

  • 40. Probiotic potential of Saccharomyces strains isolated from Litchi chinensis (Lychee fruit).
    Khan M; Ahmed I; Farooq S; Khan S; Amin R; Ali S
    Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1855-1861. PubMed ID: 33612470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.